A source-linked view of every Bivalirudin study in the current snapshot—status, phase, enrollment, results, publications, locations and changes over time.
Largest indexed study
7,200 participants · NCT01433627 →Developer / research origin
The Medicines Company
Evidence summary
Bivalirudin appears in 75 indexed studies: 6 recruiting, 31 completed and 14 with registry results posted. The highest registered development stage in this snapshot is Phase 4. These counts measure registry activity; they do not establish that Bivalirudin is safe or effective.
Review the design, endpoints, population, protocol changes, statistical analysis and publications before drawing conclusions.
Current studies
Completed studies
Stopped studies
Duke University · Coronavirus Infection (COVID-19) · Pulmonary Arterial Hypertension
Not applicable
Recruiting
5,000
2026-07
Sydney Local Health District · Extracorporeal Membrane Oxygenation Complication
Phase 2
Recruiting
80
2026-05
Xiaotong Hou · Extracorporeal Membrane Oxygenation Complication
Not applicable
Recruiting
154
2026-04
Shenyang Northern Hospital · Percutaneous Coronary Intervention · High Bleeding Risk
Phase 4
Not yet recruiting
5,270
2026-02
Stanford University · Heart Failure · Cardiogenic Shock
Phase 2
Recruiting
50
2026-01
NYU Langone Health · Coronary Microvascular Disease · Ischemic Heart Disease
Not applicable
Active, not recruiting
206
2025-11
Shenyang Northern Hospital · ST Elevation Myocardial Infarction
Not applicable
Completed
6,016
2025-08
Beijing Anzhen Hospital · STEMI - ST Elevation Myocardial Infarction
Phase 4
Completed
2,989
2023-05
University of Texas Southwestern Medical Center · Extracorporeal Membrane Oxygenation Complication · Pediatric ALL
Phase 4
Completed
30
2023-01
University Magna Graecia · Acute Respiratory Failure · SARS CoV 2 Infection
Not applicable
Completed
58
2022-08
Nanjing First Hospital, Nanjing Medical University · Coronary Heart Disease
Not applicable
Completed
330
2022-08
Han Yaling, MD · Acute Coronary Syndrome
Phase 4
Completed
204
2021-08
Johns Hopkins University · Extracorporeal Membrane Oxygenation Complication
Phase 1
Withdrawn
0
2021-01
The Medicines Company · Heparin-Induced Thrombocytopenia · Heparin-induced Thrombocytopenia and Thrombosis Syndrome
Phase 4
Withdrawn
0
2020-10
Centre Hospitalier de PAU · Coronary Artery Disease
Phase 4
Terminated
99
2019-05
The Medicines Company · Acute Myocardial Infarction
Phase 3
Terminated
78
2018-10
Kaiser Permanente · Percutaneous Coronary Intervention
Phase 3
Terminated
250
2018-05
Medicure · Myocardial Infarction · Acute Coronary Syndromes
Phase 3
Withdrawn
0
2018-03
Full study index
Add status, phase, condition, country, result and publication filters inside this molecule’s indexed study set.
75 matching studies
Last registry update first
Latest publications
Related pages
Commercial research listings, where present, are kept separate from clinical evidence and are not treatment recommendations.